Jeannette Bankes, President and General Manager for the Global Surgical Franchise at Alcon, learned early in her career that she had an interest not only in the complexity of vaccine and pharmaceutical development, but also in the business that drove that development. Her combination of scientific passion and business expertise led Jeannette to become one of the first women with a scientist-technical background to hold a GM role at Boston Scientific, and to lead what is now a $5 billion-per-year surgical franchise within the world’s largest eyecare device company.Take a listen as Jeannette discusses with host Rob Rothman, MD, why she transitioned from the pharmaceutical industry to the medical device industry and how she developed the business acumen to succeed as a GM. She also shares what’s on the horizon for Alcon and why the company values their strategic partners.Pres Play and you will also learn:What a company like Alcon looks for in early- and late-stage innovation partners.How Alcon maintains its dominance despite fierce competition.How Alcon plans to utilize digital health and data science to improve phacoemulsification (phaco).The unsolved ophthalmic problems that Alcon plans to focus on over the next 10 years.